ND Biosciences awarded a grant from The Michael J. Fox Foundation to accelerate the development of its assays
Innovating Through Embracing Complexity
ND Biosciences was founded to develop next-generation therapeutics and diagnostics for neurodegenerative diseases
Play Video
About us
About us
ND Biosciences was founded to develop next-generation therapeutics and diagnostics for neurodegenerative diseases (NDs).
The therapies developed at ND Biosciences focus on treating both
early and late stages of NDs. This is accomplished by developing
combination therapies that prevent the initiation of pathological
protein aggregation observed in NDs, and that neutralize the activities
of existing protein aggregates.
ND Biosciences has developed integrated proprietary platforms that
enable its transformative drug discovery and preclinical development
programs. These platforms are based on unique capabilities and model
systems that allow ND Biosciences to:
- Reverse-engineer the complexity of protein aggregates observed in NDs under controlled conditions
- Model key processes underlying the formation of protein pathologies and neurodegeneration in living neurons
- Develop novel companion diagnostic assays and imaging agents that capture the diversity and complexity of protein pathology in patient’s brains
Supported by
Our Science
Our Science
our Publications
The technologies and innovative tools and discovery platforms employed by ND-BioSciences are based on more than 15 years of innovation and pioneering work that was carried out in the laboratory of its founder, Dr. Hilal A. Lashuel and are well-documented in several high impact peer-reviewed publications.
Latest News
ND-BioSciences Announces partnership with The Michael J. Fox Foundation for parkinson’s research to make available unique synuclein proteoforms
ND BioSciences, a Swiss-based biotechnology company that was
ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology
La start-up qui veut combattre les maladies neurodégénératives par des traitements novateurs
The biotech start-up based at Biopôle is developing innovative technologies for early diagnostics and therapies
The development of disease models that recapitulate the key pathological and clinical features of neurodegenerative diseases
ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology
ND BioSciences, a Swiss-based biotechnology company that was
ND BioSciences, a Swiss-based biotechnology company that was